Skip to main content
SpringerLink
Log in

Breast Scintigraphy

  • Chapter
Breast Cancer

Part of the book series: M.D. Anderson Solid Tumor Oncology Series ((MDA))

  • 161 Accesses

Abstract

It was estimated that more than 180,000 new cases of breast cancer would be diagnosed among women in the United States during 1997 and that breast cancer would be responsible for 17% of women’s cancer deaths.1 Approximately one of every nine women develops breast cancer by age 85. The American Cancer Society recommends that women have their first screening mammogram by age 40, again every 1–2 years between the ages of 40 and 49, and yearly after age 50. In addition, a clinical physical examination of the breast is recommended every 3 years for women aged 20–40 and every year for those older than 40. The American Cancer Society also recommends monthly breast self-examination for women 20 years or older.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin 1992;47(l):5–27.

    Google Scholar 

  2. Parker SH, Burbank F, Jackson RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994;193:359.

    PubMed  CAS  Google Scholar 

  3. Sneige N. Fine needle aspiration of the breast: a review of 1995 cases with the emphasis on diagnostic pitfalls. Diagn Cytopathol 1993;9:106–112.

    Article  PubMed  CAS  Google Scholar 

  4. Sneige N, Fornage BD, Saleh G. Ultrasound-guided fine needle aspiration of nonpalpable breast lesions. Am J Clin Pathol 1994;102:98–101.

    PubMed  CAS  Google Scholar 

  5. Rosner D, Bedwani RN, Vana J, et al. Noninvasive breast carcinomas: results of a national survey by the American College of Surgeons. Ann Surg 1980;192:139–147.

    Article  PubMed  CAS  Google Scholar 

  6. Rosner D, Lane WW, Penetrante R. Ductal carcinoma in situ with microinvasion: a curable entity using surgery alone without need for adjuvant therapy. Cancer 1991;67:1498–1503.

    Article  PubMed  CAS  Google Scholar 

  7. Bland KI, Copeland EM III (eds). The Breast. Philadelphia: Saunders, 1991;318–326.

    Google Scholar 

  8. Piccolo S, Lastoria S, Mainolli C, et al. Technetium-99m methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 1995;36:718–725.

    PubMed  CAS  Google Scholar 

  9. Burnett KR, Lyons KP, Theron-Brown W. Uptake of osteotropic radionuclides in the breast. Semin Nucl Med 1984;14:48–49.

    Article  PubMed  CAS  Google Scholar 

  10. Uno K, Uchida Y, Sakata S, et al. Visualization of female breast in bone scintigraphy. Kaku Igaku 1992;29:1201–1206.

    PubMed  CAS  Google Scholar 

  11. Waxman AD, Ramanna L, Mesmic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993;34:18–23.

    PubMed  CAS  Google Scholar 

  12. Lee VW, Sax EJ, McAneny DB, et al. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993;34:2095–2100.

    PubMed  CAS  Google Scholar 

  13. Schweil AM, McKillop JH, Milroy R, et al. Thallium-201 scintigraphy in the staging of lung cancer, breast cancer and lymphoma. Nucl Med Commun 1990;11:263–269.

    Article  Google Scholar 

  14. Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors: preliminary results and comparison with Tl-201. Clin Nucl Med 1992;17:171–176.

    Article  PubMed  CAS  Google Scholar 

  15. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994;178:491–497.

    PubMed  CAS  Google Scholar 

  16. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 1994;21:357–362.

    Article  PubMed  CAS  Google Scholar 

  17. Kao CH, Wang SJ, Yeh SH. Technetium-99m MIBI uptake in breast carcinoma and axillary lymph node metastases. Clin Nucl Med 1994;19:898–900.

    Article  PubMed  CAS  Google Scholar 

  18. Waxman A, Nagaraj N, Ashok G, et al. Sensitivity and specificity of Tc-99m methoxy isobutyle isonitrile (MIBI) in the evaluation of primary carcinoma of the breast: comparison of palpable and nonpalpable lesions with mammography [abstract]. J Nucl Med 1994;35:22P.

    Google Scholar 

  19. Nagaraj N, Waxman A, Ashok G, et al. Comparison of SPECT and planar Tc-99m sestamibi (MIBI) imaging in patients with carcinoma of the breast [abstract]. J Nucl Med 1994;35:229P.

    Google Scholar 

  20. Burak Z, Argon M, Memix A, et al. Evaluation of palpable breast masses with Tc-99m MIBI: a comparative study with mammography and ultrasonography. Nucl Med Commun 1994;15:604–612.

    PubMed  CAS  Google Scholar 

  21. Waxman AD, Ashok G, Kooba A, et al. The use of Tc-99m methoxy isobutyl isonitrile (MIBI) in evaluation of patients with primary carcinoma of the breast: comparison with Tl-201 (Tl) [abstract]. J Nucl Med 1993;34(suppl):139P.

    Google Scholar 

  22. Khalkhali I, Mena I, Jousnne E, et al. Technetium-99m sestamibi MIBI prone breast imaging in patients with suspicion of breast cancer [abstract]. J Nucl Med 1993;34(suppl):140P.

    Google Scholar 

  23. Taillefer R, Robidoux A, Lambert R, et al. Technetium-99m sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758–1765.

    PubMed  CAS  Google Scholar 

  24. Khalkhali I, Cutrone JA, Mena I, et al. Technetium-99m sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784–1789.

    PubMed  CAS  Google Scholar 

  25. Palmedo H, Schomburg A, Grunwald F, et al. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626–630.

    PubMed  CAS  Google Scholar 

  26. Khalkhali I, Villanueva-Meyer J, Edell SL, et al. Impact of breast density on the diagnostic accuracy of Tc-99m sestamibi breast imaging in the detection of breast cancer [abstract]. J Nucl Med 1996;37:74P

    Google Scholar 

  27. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis (alkylisionitrile) technetium-99 complexes. J Nucl Med 1990;31:1166–1167.

    PubMed  CAS  Google Scholar 

  28. Waxman A, Nagaraj N, Kovalevsky M, et al. Detection of primary breast malignancy with Tc-99m methoxyisobutylisonitrile (MIBI) in patients with non-palpable primary malignancies: the importance of lesion size [abstract]. J Nucl Med 1995;36:194.

    Google Scholar 

  29. Gupta P, Waxman A, Nguyen K, et al. Correlation of Tc-99m sestamibi uptake with histopathologic characteristics in patients with benign breast disease [abstract]. J Nucl Med 1996;1122:P250.

    Google Scholar 

  30. Waxman AD. The role of Tc-99m methoxisobutylisonitrile in imaging of breast cancer. Semin Nucl Med 1997;27:40–54.

    Article  PubMed  CAS  Google Scholar 

  31. Carvalho PA, Chiu ML, Kranaug JF, et al. Subcellular distribution and analysis of Tc-99m MIBI in isolated perfused rat hearts. J Nucl Med 1992;33:1516–1521.

    PubMed  CAS  Google Scholar 

  32. Piwnica-Worms D, Chiu ML, Budding M, et al. Functional imaging of multidrug resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977–984.

    PubMed  CAS  Google Scholar 

  33. Tse NY, Hoh CK, Hawkins RA, et al. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg 1992;216:27–34.

    Article  PubMed  CAS  Google Scholar 

  34. Wahl RL, Cody RL, Hutchins GD, et al. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1991;179:765–770.

    PubMed  CAS  Google Scholar 

  35. Nabi HA, Seldin D, Barron B, et al. CEA-Scan radioimmunodetection of primary breast lesions: results of phase II multicenter trial [abstract]. Eur J Nucl Med 1995;22.

    Google Scholar 

  36. Nabi H, Rosner D, Erb D, et al. Evaluation of suspicious mammographic findings with CEA-Scan and correlation with histopathological results [abstract]. J Nucl Med 1996;238.

    Google Scholar 

  37. Maffioli L, Agresti R, Chita A, et al. Prone scintimammography in patients with non-palpable breast lesions [abstract]. Anticancer Res 1996;16:1269–1273.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Ebrahim S. Delpassand
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Surgical Breast Section, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Box 106, 1515 Holcombe Boulevard, Houston, TX, 77030, USA

    S. Eva Singletary M.D., FACS (Professor of Surgery, Chief) (Professor of Surgery, Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Delpassand, E.S. (1999). Breast Scintigraphy. In: Singletary, S.E. (eds) Breast Cancer. M.D. Anderson Solid Tumor Oncology Series. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2146-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2146-3_4

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7432-2

  • Online ISBN: 978-1-4612-2146-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation